-+ 0.00%
-+ 0.00%
-+ 0.00%

INCYTE JAPAN ANNOUNCES APPROVAL OF ZYNYZ® (RETIFANLIMAB) FOR THE FIRST-LINE TREATMENT OF ADVANCED ANAL CANCER

Reuters·12/22/2025 07:42:00

Please log in to view news